Moving from efficacy to effectiveness: budesonide multimatrix in ulcerative colitis

United European Gastroenterol J. 2019 Nov;7(9):1153-1155. doi: 10.1177/2050640619878588. Epub 2019 Sep 22.

Authors

Fernando Magro^{1

2

3}, Maria Manuela Estevinho¹

Affiliations

¹ Department of Biomedicine, University of Porto, Porto, Portugal.
² Department of Gastroenterology, Centro Hospitalar São João, Porto, Portugal.
³ MedInUP, Center for Drug Discovery and Innovative Medicines, Porto, Portugal.

No abstract available

Publication types

Editorial

MeSH terms

Anti-Inflammatory Agents, Non-Steroidal / therapeutic use
Budesonide* / therapeutic use
Colitis, Ulcerative* / diagnosis
Colitis, Ulcerative* / drug therapy
Humans
Mesalamine / therapeutic use

Substances

Budesonide
Anti-Inflammatory Agents, Non-Steroidal
Mesalamine